2020
DOI: 10.1186/s12882-020-02090-3
|View full text |Cite
|
Sign up to set email alerts
|

Impact of serum phosphate changes on in-hospital mortality

Abstract: Background Fluctuations in serum phosphate levels increased mortality in end-stage renal disease patients. However, the impacts of serum phosphate changes in hospitalized patients remain unclear. This study aimed to test the hypothesis that serum phosphate changes during hospitalization were associated with in-hospital mortality. Methods We included all adult hospitalized patients from January 2009 to December 2013 that had at least … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 20 publications
(22 citation statements)
references
References 39 publications
(54 reference statements)
1
21
0
Order By: Relevance
“…An oversampling strategy (Synthetic Minority Oversampling Technique -SMOTE) was used to overcome the unbalancing of the two classes for outcomes (discharged patients -class 0-and deceased patients -class 1) 17 .…”
mentioning
confidence: 99%
“…An oversampling strategy (Synthetic Minority Oversampling Technique -SMOTE) was used to overcome the unbalancing of the two classes for outcomes (discharged patients -class 0-and deceased patients -class 1) 17 .…”
mentioning
confidence: 99%
“…The kidney is an important regulator of phosphorus homeostasis, and hypophosphatemia can be caused by poor phosphorus intake/intestinal absorption, redistribution from extracellular to intracellular compartments (refeeding syndrome and respiratory alkalosis), and/or excessive urinary phosphate excretion [ 7 , 16 , 31 ]. Upon hospital admission, the findings of our ML consensus clustering suggest that kidney functions (surrogates included baseline eGFR and AKI on admission) played an important role in differentiating the phenotypes of patients with hypophosphatemia.…”
Section: Discussionmentioning
confidence: 99%
“…Compared with Cluster 1, Cluster 2 had more principal diagnoses of cardiovascular, genitourinary, and hematoma oncology. Hypophosphatemia in Cluster 2 could be a surrogate marker of illness, or related to comorbidities and their treatment [ 7 , 33 ]. For instance, diabetes mellitus being treated with insulin therapy is another common comorbidity that is associated with hypophosphatemia.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations